www.finanzen.net bietet Finanznachrichten zum weltweiten Boersengeschehenhttp://www.finanzen.netde-definanzen.net GmbHhttp://images.finanzen.net/images/finanzen_net_neu.gifhttp://www.finanzen.nethttp://www.finanzen.net/nachricht/Rogers-Corporation-Announces-Agreement-to-Acquire-SK-Utis-Co-Ltd-761661 <style type="text/css"> <!-- .bwtextaligncenter {text-align: center} --> </style> <a href="/aktien/Rogers-Aktie">Rogers</a> Corporation (NYSE: ROG) announced today that it has signed an agreement with SK Chemicals Co. Ltd. of South ...http://www.finanzen.net/nachricht/Rogers-Corporation-Announces-Agreement-to-Acquire-SK-Utis-Co-Ltd-761661http://www.finanzen.net/nachricht/Genentech-Submits-Supplemental-Biologics-License-Application-for-ACTEMRA-tocilizumab-for-Prevention-of-Structural-Joint-Damage-and-Improvement-of-Physical-Function-in-Rheumatoid-Arthritis-758115 <style type="text/css"> <!-- .bwtextaligncenter {text-align: center} .bwunderlinestyle {text-decoration: underline} --> </style> <!-- sh_cad_1 --> Genentech, Inc., a wholly-owned member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), ...http://www.finanzen.net/nachricht/Genentech-Submits-Supplemental-Biologics-License-Application-for-ACTEMRA-tocilizumab-for-Prevention-of-Structural-Joint-Damage-and-Improvement-of-Physical-Function-in-Rheumatoid-Arthritis-758115http://www.finanzen.net/nachricht/Genentech-Provides-Update-on-Phase-III-Study-of-Avastin-in-Men-With-Late-Stage-Prostate-Cancer-756281 <style type="text/css"> <!-- .bwtextaligncenter {text-align: center} --> </style> Genentech, Inc., a wholly owned member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today the topline results of a Phase III trial ...http://www.finanzen.net/nachricht/Genentech-Provides-Update-on-Phase-III-Study-of-Avastin-in-Men-With-Late-Stage-Prostate-Cancer-756281http://www.finanzen.net/nachricht/Genentech-Announces-Positive-Results-of-Avastin-Phase-III-Study-in-Women-with-Advanced-Ovarian-Cancer-747900 <style type="text/css"> <!-- .bwlistitemmarginbottom {margin-bottom: 10.0px} .bwtextaligncenter {text-align: center} --> </style> <!-- sh_cad_1 --> Genentech, Inc., a wholly owned member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), ...http://www.finanzen.net/nachricht/Genentech-Announces-Positive-Results-of-Avastin-Phase-III-Study-in-Women-with-Advanced-Ovarian-Cancer-747900http://www.finanzen.net/nachricht/Phase-III-Study-of-Avastin-Plus-Chemotherapy-in-Advanced-Stomach-Cancer-Did-Not-Meet-Primary-Endpoint-746291 <style type="text/css"> <!-- .bwtextaligncenter {text-align: center} --> </style> Genentech, Inc., a wholly owned member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that a Phase III study (AVAGAST) did not ...http://www.finanzen.net/nachricht/Phase-III-Study-of-Avastin-Plus-Chemotherapy-in-Advanced-Stomach-Cancer-Did-Not-Meet-Primary-Endpoint-746291http://www.finanzen.net/nachricht/Rogers-Corporation-Reports-2009-Fourth-Quarter-and-Full-Year-Results-744935 <style type="text/css"> <!-- .bwcellpaddingbottom1 {padding-bottom: 2.0px} .bwcellpaddingleft0 {padding-left: 0.0px} .bwcellpaddingleft2 {padding-left: 10.0px} .bwcellpaddingleft3 {padding-left: 15.0px} .bwcellpaddingleft4 {padding-left: 20.0px} .bwcellpaddingleft6 ...http://www.finanzen.net/nachricht/Rogers-Corporation-Reports-2009-Fourth-Quarter-and-Full-Year-Results-744935http://www.finanzen.net/nachricht/Rogers-Corporation-Invites-You-to-Join-its-2009-Fourth-Quarter-and-Year-End-Earnings-Conference-Call-741485 <a href="/aktien/Rogers-Aktie">Rogers</a> Corporation (NYSE: ROG) plans to announce results for its 2009 fourth quarter and year-end after the close of trading on Thursday, February 18, 2010. A copy of the release will be ...http://www.finanzen.net/nachricht/Rogers-Corporation-Invites-You-to-Join-its-2009-Fourth-Quarter-and-Year-End-Earnings-Conference-Call-741485http://www.finanzen.net/nachricht/Rogers-Corporation-Announces-Three-Significant-Mass-Transit-Project-Awards-for-its-BISCO-Silicones-726080 <style type="text/css"> <!-- .bwtextaligncenter {text-align: center} --> </style> <a href="/aktien/Rogers-Aktie">Rogers</a> Corporation (NYSE:ROG) a global technology leader in the development and manufacture of high performance ...http://www.finanzen.net/nachricht/Rogers-Corporation-Announces-Three-Significant-Mass-Transit-Project-Awards-for-its-BISCO-Silicones-726080http://www.finanzen.net/nachricht/Rogers-Corporation-to-Present-at-CJS-Securities-Inc-Tenth-Annual-New-Ideas-for-the-New-Year-Investor-Conference-724404 <style type="text/css"> <!-- .bwtextaligncenter {text-align: center} --> </style> <a href="/aktien/Rogers-Aktie">Rogers</a> Corporation (NYSE:ROG) will be presenting at the Tenth Annual CJS Securities "New Ideas for the New Year” ...http://www.finanzen.net/nachricht/Rogers-Corporation-to-Present-at-CJS-Securities-Inc-Tenth-Annual-New-Ideas-for-the-New-Year-Investor-Conference-724404http://www.finanzen.net/nachricht/Rogers-Corporation-Issues-Guidance-for-the-Full-Year-2010-and-Updates-Sales-Guidance-for-the-Fourth-Quarter-of-2009-723980 <style type="text/css"> <!-- .bwtextaligncenter {text-align: center} --> </style> <a href="/aktien/Rogers-Aktie">Rogers</a> Corporation (NYSE:ROG) today announced guidance for the full year 2010. The Company has not historically ...http://www.finanzen.net/nachricht/Rogers-Corporation-Issues-Guidance-for-the-Full-Year-2010-and-Updates-Sales-Guidance-for-the-Fourth-Quarter-of-2009-723980